06.12.2013 • NewsDede WillamsEPAspeciality chemicals

EPA Fines Elementis Chromium Over Non-Disclosure of Chemical Risk

Elementis Chromium, one of the world's largest manufacturers of chromium chemicals in the world, has been fined $2,571,800 for failing to disclose information about the negative health effects on workers of exposure to hexavalent chromium. Disclosure is required by the Toxic Substances Control Act (TSCA) as the substance has been identified as a carcinogen.

The EPA's complaint against the New Jersey-based speciality chemicals producer was filed with the Office of Administrative Law Judges in September 2010. The company has manufactured and distributed chromium-based chemical substances and mixtures for more than 35 years and has plants in Castle Hayne, North Caroline and Corpus Christi, Texas.

 

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.